logo

For the Inventor, By the Inventor

New Palestine, IN, United States of America

Charles L Hershberger

USPTO Granted Patents = 23

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 186(Granted Patents)


Location History:

  • New Palestine, IN (US) (1982 - 1997)
  • Greenfield, IN (US) (1997 - 2003)

Company Filing History:

goldMedal23 out of 4,447 
 
Eli Lilly and Company
 patents
silverMedal1 out of 13 
 
Baxter Biotech Technology Sarl
 patents
where one patent can have more than one assignee

Years Active: 1982-2003

Loading Chart...
23 patents (USPTO):Explore Patents
1. 6531308 - Ketoreductase gene and protein from yeast (2003-03-11),
2. 6136565 - Methods of reducing the levels of protoporphyrin IX in recombinant (2000-10-24),
3. 6027911 - Bovine dipeptidylaminopeptidase 1 (2000-02-22),
4. 6008041 - Bovine dipeptidylaminopeptidase 1 (1999-12-28),
5. 5672497 - Method for increasing the antibiotic-producing ability of (1997-09-30),
6. 5672496 - DNA sequences encoding porcine pancreatic carboxypeptidase B (1997-09-30),
7. 5576190 - Bacteriophage Lambda pL promoters (1996-11-19),
8. 5395761 - Plasmid pHKY334, an expression vector for EK-BGH and host cells (1995-03-07),
9. 4898828 - Ultrahigh copy number streptomycetes plasmids (1990-02-06),
10. 4753886 - Plasmid PHJL210 and related bifunctional cloning vectors for use in (1988-06-28),
11. 4752574 - Chimeric cloning vectors for use in streptomyces and E. Coli (1988-06-21),
12. 4732859 - Method for conferring bacteriophage resistance to bacteria (1988-03-22),
13. 4710466 - Method of cloning modified streptomycetes DNA (1987-12-01),
14. 4663282 - Glycopeptide antibiotic CUC/CSV and process for its production (1987-05-05),
15. 4650761 - Method for stabilizing and selecting recombinant DNA containing host cell (1987-03-17),

Title: Innovations and Contributions of Charles L. Hershberger

Introduction: Charles L. Hershberger, a prominent inventor based in New Palestine, Indiana, has made significant contributions to the field of biotechnology. With a total of 23 patents to his name, his innovative work has impacted various domains within biochemistry and molecular biology.

Latest Patents: Among his latest inventions is the development of the ketoreductase gene and protein from yeast. This groundbreaking invention includes cloned ketoreductase genes, vectors for their expression, and recombinant host cells that express these vector-borne genes. It also provides a method for stereospecifically reducing a ketone using a recombinant ketoreductase, as well as a recombinant host cell that expresses a cloned ketoreductase gene. Additionally, he has devised methods for generating polynucleotide sequences that are more conducive to recombinant expression. Another notable patent involves methods of reducing the levels of protoporphyrin IX in recombinant systems.

Career Highlights: Throughout his career, Hershberger has worked with leading companies in the biotechnology sector, including Eli Lilly and Company and Baxter BioTech Technology Sarl. His expertise in molecular biology and genetics has positioned him as a vital contributor to innovations in the field.

Collaborations: Hershberger's collaborative efforts with esteemed colleagues, such as Paul R. Rosteck, Jr. and Jeffrey L. Larson, have resulted in pioneering research and development projects, further advancing the realms of biotechnology and pharmaceuticals.

Conclusion: Charles L. Hershberger's prolific contributions to patentable inventions and collaborations with key industry figures highlight his status as an influential figure in biotechnology. His work continues to inspire future innovations and improve methodologies in recombinant expression and biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…